High cholesterol, or hypercholesterolemia, affects nearly 1 in 3 American adults—yet it often goes undetected until a serious event like a heart attack or stroke occurs. It's one of the major ...
The FDA approved lerodalcibep (Lerochol) injections for the treatment of elevated LDL cholesterol in adults, maker LIB Therapeutics announced. A third-generation PCSK9 inhibitor, lerodalcibep is ...
LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga. The injected treatment, which will carry the commercial name Lerochol, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results